Improving anticancer activities of Oplopanax horridus root bark extract by removing water-soluble components

Phytotherapy Research

Volumn 24, Issue 8, 2010, Pages 1166-1174

  Sun, Shi ^a   Li, Xiao Li ^a   Wang, Chong Zhi ^a   Williams, Stainley ^a   Yuan, Chun Su ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Antiproliferative effect; Apoptosis; Cell cycle; Human breast cancer MCF 7 cells; Non small cell lung cancer (NSCLC) cells; Oplopanax horridus

Indexed keywords

ALCOHOL; OPLOPANAX HORRIDUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; IC 50; LUNG NON SMALL CELL CANCER; OPLOPANAX; OPLOPANAX HORRIDUS; PLANT ROOT; CELL CYCLE; CHEMISTRY; DRUG EFFECTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TUMOR CELL LINE;

OPLOPANAX HORRIDUS;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETHANOL; HUMANS; OPLOPANAX; PLANT EXTRACTS; PLANT ROOTS;

EID: 77955617901     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3061     Document Type: Article

References (36)

1. Academy of Traditional Chinese Medicine and Traditional Chinese Herb of Ji-lin Province. 1982. Changbaishan Plant Materia Medica. People's Medical Publishing House of Ji-lin: Changchun; 785.
2. Artyukova EV, Gontcharov AA, Kozyrenko MM, Reunova GD, Zhuravlev YN. 2005. Phylogenetic Relationships of the Far Eastern Araliaceae Inferred from ITS Sequences of Nuclear rDNA. Russ J Gene 41: 649-658. (Pubitemid 41125786)
3. Bloxton JD, II, Marderosian AD. 2002. Bioactive Constituents of Alaskan Devil's Root (Oplopanax horridus, Araliaceae). Economic Botany 56: 285-287.
4. Budavari S. (ed.) 1989. The Merck Index. Merck & Co: Rabway.
5. Christensen LP, Brandt K. 2006. Bioactive polyacetylenes in food plants of the Apiaceae family: Occurrence, bioactivity, and analysis. J Pharma Biomed Anal 41: 683-693.
6. Gruber JW, Kittipongpatana N, Bloxton JD, II, Der Marderosian A, Schaefer FT, Gibbs R. 2004. High-performance liquid chromatography and thin-layer chromatography assays for devil's club (Oplopanax horridus). J Chromatogr Sci 42: 196-199.
7. Guo L, Song L, Wang Z, Zhao W, Mao W, Yin M. 2009. Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2. Chem Biol Interact 181: 138-43.
8. Inui T, Wang Y, Deng S, Smith DC, Franzblau SG, Pauli GF. 2007. Counter-current chromatography based analysis of synergy in an anti-tuberculosis ethnobotanical. J Chromatogr A 1151: 211-215. (Pubitemid 46679002)
9. Inui T. 2008. Phytochemical and biochemometric evaluation of the Alaskan anti-TB ethnobotanical: Oplopanax horridus. University of Illinois at Chicago: Chicago; 187 p.
10. Johnson LM. 2006. Gitksan medicinal plants - cultural choice and efficacy. J Ethnobiol Ethnomed 2: 29.
11. Kang KA, Kang JH, Yang MP. 2008. Ginseng total saponin enhances the phagocytic capacity of canine peripheral blood phagocytes in vitro. Am J Chin Med 36: 329-41.
12. Kariyone T, Morotomi S. 1927. The essential oil of Echinopanax horridus, Decne et Planch. Yakugaku Zasshi 546: 671-674.
13. Kobaisy M, Abramowski Z, Lermer L, Saxena G, Hancock RE, Towers GH, Doxsee D, Stokes RW. 1997. Antimycobacterial polyynes of Devil's Club (Oplopanax horridus), a North American native medicinal plant. J Nat Prod 60: 1210-1213. (Pubitemid 27516227)
14. Laboratoires Meram. Assignee. 1966. Terpene alcohol sedatives and spasmolytics. Application: FR patent M4055, 19640120.
15. Lantz TC, Swerhun K, Turner NJ. 2004. Devil's Club (Oplopanax horridus): An Ethnobotanical Review. HerbalGram: J Am Bot Counc 62: 33-48.
16. Large RG, Brocklesby HN. 1938. A hypoglucemic substance from the roots of the devil's club (Fatsia horrida). Cana Med Assoc J 39: 32-5.
17. Lowe SW, Lin AW. 2000. Apoptosis in cancer. Carcinogenesis 21: 485-495.
18. McCutcheon AR, Roberts TE, Gibbons E, Ellis SM, Babiuk LA, Hancock RE, Towers GH. 1995. Antiviral screening of British Columbian medicinal plants. J Ethnopharmacol 49: 101-110. (Pubitemid 26010743)
19. McCutcheon AR, Stokes RW, Thorson LM, Ellis SM, Hancock REW, Towers GHN. 1997. Anti-Mycobacterial Screening of British Columbian Medicinal Plants. Pharmaceut Biol 35: 77-83. (Pubitemid 127700238)
20. Moore M. 1993. Medicinal plants of the Pacific West. Red Crane Books: Santa Fe; 125-128.
21. Pucci B, Kasten M, Giordano A. 2000. Cell cycle and apoptosis. Neoplasia (New York) 2: 291-299.
22. Sandal T. 2002. Molecular aspects of the mammalian cell cycle and cancer. Oncologist 7: 73-81. (Pubitemid 34151110)
23. Schofield JJ. 2000. Discovering wild plants: Alaska, Western Canada, The Northwest. Alaska Northwest Books: Portland; 87-89.
24. Smith GW. 1983. Arctic pharmacognosia II. Devil's Club, Oplopanax horridus. J Ethnopharmacol 7: 313-20.
25. Tai J, Cheung S, Cheah S, Chan E, Hasman D. 2006. In vitro antiproliferative and antioxidant studies on Devil's Club Oplopanax horridus. J Ethnopharmacol 108: 228-235. (Pubitemid 44635035)
26. Takeda K, Minato H, Ishikawa M. 1966. Studies on sesquiterpenoids. XII. Structure and absolute configuration of oplopanone, a new sesquiterpene from Oplopanax japonicus. Tetrahedron, Supplement 11: 219-25.
27. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS. 2007a. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 73: 669-674. (Pubitemid 47066161)
28. Wang CZ, Ni M, Sun S, Li XL, He H, Mehendale SR, Yuan CS. 2009. Detection of adulteration of notoginseng root extract with other panax species by quantitative HPLC coupled with PCA. J Agric Food Chem 57: 2363-2367.
29. Wang CZ, Yuan CS. 2008. Potential role of ginseng in the treatment of colorectal cancer. Am J Chin Med 36: 1019-1028.
30. Wang G. 2006. The Studies on the oleanane-type triterpenoid saponins and lupene-type triterpenoid saponins in Chinese herbs oplopanax elatus and achyranthes bidentata. Jilin University: Changchun.
31. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H, Zhang R. 2007b. In vitro anticancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 59: 589-601. (Pubitemid 46295123)
32. Wattenberg LW. 1991. Inhibition of azoxymethane-induced neoplasia of the large bowel by 3-hydroxy-3,7,11-trimethyl-1,6,10-dodecatriene (nerolidol). Carcinogenesis 12: 151-152.
33. Welburn JPI, Endicott JA. 2005. Inhibition of the cell cycle with chemical inhibitors: A targeted approach. Seminars in Cell & Developmental Biology 16: 369-381. (Pubitemid 40504225)
34. Xiang Q, Lowry PP. 2007. Araliaceae In Flora of China, Wu Z, Raven PH, Hong D, (eds). Science Press & Missouri Botanical Garden: Beijing & St Louis, MO, USA; 441.
35. Yun TK, Yun YS, Han IW. 1983. Anticarcinogenic effect of long-term oral administration of red ginseng on newborn mice exposed to various chemical carcinogens. Cancer Detect Prev 6: 515-525.
36. Zuo G, Guan T, Chen D, Li C, Jiang R, Luo C, Hu X, Wang Y, Wang J. 2009. Total saponins of Panax ginseng induces K562 cell differentiation by promoting internalization of the erythropoietin receptor. Am J Chin Med 37: 747-757.